A Boston-area cancer research lab will lay off more than 100 employees later this year, according to a new filing with the state. Mural Oncology in Waltham will lay off 117 people between June 14 and ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...

PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI's pathology universal transformer (PLUTO) foundation model and portfolio ...

The billion-dollar project will be faster, stronger and twice the size of MU's current research reactor with the ability to ...

A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, according to research led by University of Arizona Cancer Center researchers ...

Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat ...

Voters might not have appreciated that a Republican victory in the 2024 elections would mean sweeping cuts to cancer research, but here we are.